0000950170-23-022241 Sample Contracts

ASSET PURCHASE AGREEMENT by and between QUINCE THERAPEUTICS, INC. and LIGHTHOUSE PHARMACEUTICALS, INC. dated January 27, 2023

Asset Purchase Agreement • May 15th, 2023 • Quince Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Asset Purchase Agreement
• Filed
  May 15th, 2023
• Company
  Quince Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS ASSET PURCHASE AGREEMENT (this “APA” or “Agreement”), dated as of January 27, 2023 (the “Execution Date”), is made by and between Quince Therapeutics, Inc., a Delaware corporation (“Seller”), and Lighthouse Pharmaceuticals, Inc., a Delaware corporation (“Purchaser”). In this APA, Seller and Purchaser are individually referred to as a “Party” and collectively as the “Parties.”